Answers are grounded in this paper and cite their sources.
Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.
No takes yet. Share an insight, caveat, or question.
Weaver et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: